• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Autodesk: Leading Design Software With Resilient Growth, Sustainable Profitability (ADSK)

November 17, 2022 admin 0

Olemedia Investment thesis Autodesk (NASDAQ:ADSK) provides a unique investment opportunity to invest into leading company providing leading design software for global companies. In my view, the company looks set to continue to grow in the […]

Stock News

It Could Be A Little Early For JNUG

November 17, 2022 admin 0

naisupakit/iStock via Getty Images Published on the Value Lab 11/15/22 The Direxion Daily Junior Gold Miners Index Bull (NYSEARCA:JNUG) is an ETF that tracks gold miners such that daily close prices from previous closes vary […]

Stock News

Vivendi’s Cadoret quits TIM board for ‘personal reasons’ By Reuters

November 17, 2022 admin 0

2/2 © Reuters. FILE PHOTO: Telecom Italia (TIM) logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration 2/2 ROME (Reuters) -Frank Cadoret, one of two board members representing top investor Vivendi […]

Posts navigation

« 1 … 3,992 3,993 3,994 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Rideshare, retailers brace for tough U.S. independent contractor rule By Reuters
    September 27, 2022 0
  • Earnings Season Takeaways: The Implications For Markets And The Economy
    February 9, 2023 0
  • Facebook ad revenue seen feeling brunt of Apple privacy changes By Reuters
    October 25, 2021 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.